Healthcare provider profile · identity verified

Ritika Bhatt, MD

Internal Medicine · SPRINGFIELD, MA · NPI 1386781136

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	607	149
Amlodipine Besylate	Amlodipine Besylate	407	88
Omeprazole	Omeprazole	404	97
Lisinopril	Lisinopril	345	83
Levothyroxine Sodium	Levothyroxine Sodium	338	64
Losartan Potassium	Losartan Potassium	234	55
Gabapentin	Gabapentin	195	36
Metoprolol Succinate	Metoprolol Succinate	188	42
Metformin Hcl Er	Metformin Hcl	186	44
Carvedilol	Carvedilol	171	36
Pantoprazole Sodium	Pantoprazole Sodium	167	44
Simvastatin	Simvastatin	161	44
Eliquis	Apixaban	144	23
Albuterol Sulfate Hfa	Albuterol Sulfate	141	42
Furosemide	Furosemide	136	28
Jardiance	Empagliflozin	135	16
Mirtazapine	Mirtazapine	126	24
Pravastatin Sodium	Pravastatin Sodium	120	28
Trulicity	Dulaglutide	118	20
Fluticasone Propionate	Fluticasone Propionate	116	39
Duloxetine Hcl	Duloxetine Hcl	112	19
Fluoxetine Hcl	Fluoxetine Hcl	100	23
Hydrochlorothiazide	Hydrochlorothiazide	98	20
Rosuvastatin Calcium	Rosuvastatin Calcium	91	28
Trazodone Hcl	Trazodone Hcl	88	21
Valsartan	Valsartan	87	23
Venlafaxine Hcl Er	Venlafaxine Hcl	84	12
Alendronate Sodium	Alendronate Sodium	80	12
Tramadol Hcl	Tramadol Hcl	69	15
Oxycodone Hcl	Oxycodone Hcl	67	24
Tizanidine Hcl	Tizanidine Hcl	65	17
Chlorthalidone	Chlorthalidone	64	17
Escitalopram Oxalate	Escitalopram Oxalate	64	11
Metoprolol Tartrate	Metoprolol Tartrate	63	16
Citalopram Hbr	Citalopram Hydrobromide	61	13
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	59	11
Irbesartan	Irbesartan	57	13
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	55	12
Montelukast Sodium	Montelukast Sodium	55	13
Clopidogrel	Clopidogrel Bisulfate	53	suppressed
Farxiga	Dapagliflozin Propanediol	53	13
Atenolol	Atenolol	51	13
Lorazepam	Lorazepam	51	26
Metformin Hcl	Metformin Hcl	50	14
Wixela Inhub	Fluticasone Propion/Salmeterol	50	13
Breo Ellipta	Fluticasone/Vilanterol	49	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	49	suppressed
Bupropion Xl	Bupropion Hcl	45	11
Glipizide Er	Glipizide	44	11
Famotidine	Famotidine	43	11
Sertraline Hcl	Sertraline Hcl	40	12
Quetiapine Fumarate	Quetiapine Fumarate	39	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	39	suppressed
Potassium Chloride	Potassium Chloride	38	11
Pregabalin	Pregabalin	38	suppressed
Prednisone	Prednisone	37	31
Donepezil Hcl	Donepezil Hcl	36	suppressed
Arnuity Ellipta	Fluticasone Furoate	35	14
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	35	12
Ventolin Hfa	Albuterol Sulfate	34	11
Ozempic	Semaglutide	33	11
Allopurinol	Allopurinol	32	suppressed
Diclofenac Sodium	Diclofenac Sodium	32	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	32	suppressed
Ropinirole Hcl	Ropinirole Hcl	32	suppressed
Spironolactone	Spironolactone	32	suppressed
Warfarin Sodium	Warfarin Sodium	32	suppressed
Verapamil Er	Verapamil Hcl	29	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	28	suppressed
Baclofen	Baclofen	27	suppressed
Torsemide	Torsemide	27	suppressed
Cephalexin	Cephalexin	26	suppressed
Lidocaine	Lidocaine	26	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	26	suppressed
Ciclopirox	Ciclopirox Olamine	25	suppressed
Propranolol Hcl Er	Propranolol Hcl	25	suppressed
Azithromycin	Azithromycin	24	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	24	suppressed
Ibuprofen	Ibuprofen	23	11
Meclizine Hcl	Meclizine Hcl	22	suppressed
Synthroid	Levothyroxine Sodium	21	suppressed
Benazepril Hcl	Benazepril Hcl	20	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	20	16
Hydralazine Hcl	Hydralazine Hcl	20	suppressed
Lovastatin	Lovastatin	20	suppressed
Paroxetine Hcl	Paroxetine Hcl	20	suppressed
Xarelto	Rivaroxaban	20	suppressed
Topiramate	Topiramate	19	suppressed
Ketoconazole	Ketoconazole	18	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	17	suppressed
Diazepam	Diazepam	17	suppressed
Incruse Ellipta	Umeclidinium Bromide	17	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	17	suppressed
Meloxicam	Meloxicam	17	suppressed
Terazosin Hcl	Terazosin Hcl	17	suppressed
Valacyclovir	Valacyclovir Hcl	17	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	16	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	16	15
Bupropion Hcl Sr	Bupropion Hcl	16	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	16	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	16	suppressed
Propranolol Hcl	Propranolol Hcl	15	suppressed
Celecoxib	Celecoxib	14	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	14	suppressed
Premarin	Estrogens, Conjugated	14	suppressed
Symbicort	Budesonide/Formoterol Fumarate	14	suppressed
Clonazepam	Clonazepam	13	suppressed
Morphine Sulfate	Morphine Sulfate	13	suppressed
Ondansetron Odt	Ondansetron	13	11
Ramelteon	Ramelteon	13	suppressed
Carisoprodol	Carisoprodol	12	suppressed
Creon	Lipase/Protease/Amylase	12	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	12	suppressed
Dulera	Mometasone/Formoterol	12	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	12	suppressed
Nifedipine Er	Nifedipine	12	suppressed
Oxcarbazepine	Oxcarbazepine	12	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	12	12
Ammonium Lactate	Ammonium Lactate	11	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	11	suppressed
Dilt-Xr	Diltiazem Hcl	11	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	11	suppressed
Easy-Touch Insulin Syringe	Syringe And Needle,insulin,1ml	11	suppressed
Enalapril Maleate	Enalapril Maleate	11	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	11	suppressed
Lamotrigine	Lamotrigine	11	suppressed
Nitroglycerin	Nitroglycerin	11	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	11	11
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	11	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error